Alzheimer Disease Treatment
 

NeuroResearch Clinics, Inc.

  AMA Category 1
  Continuing Medical Education
   
   
   
   
 
HOME PAGE
 
The Cares
 
Attention Deficit ADD ADHD
Anxiety / Panic Attacks
Alzheimer Disease Treatment
Depression
Suicide
Fibromyalgia
Insomnia
Migraine headaches
Parkinson's Care
Trichotillomania
Obsessive Compulsive Disorder-OCD
 
Antidepressants
Brain Damage
Neurotransmitter Depletion
Protocols
Side Effects
neurotransmitter testing
 
University Writings About NeuroResearch Clinics
 
Neurotoxins
Technical Guide
Narrated Slide Shows
Public Interviews
Med Ed Web Site
DBS Labs Web Site
Faba Bean Warning
Webinars
Sitemap
Contact Us
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alzheimer Disease Treatment-research
Alzheimer Disease Treatment-research
Alzheimer Disease Treatment-research
 

 

Sunset Redfish Bay Fort Myers, Florida photo by Marty L. Hinz, MD  
  Alzheimer Disease Treatment-research
Alzheimer Disease Treatment

Alzheimer Disease Treatment

Contact us or find a caregiver using this approach.
 

Alzheimer Disease Treatment

Written by: Marty L. Hinz, MD
President Clinical Research
NeuroResearch Clinics, Inc.  
Cape Coral, Florida USA Research Office  
 

  Real Alzheimer Disease Treatment, where brain function is truly restored and disease is controlled, has eluded medicine. The NeuroResearch Clinics approach to Alzheimer Disease Treatment produces excellent results. 

Alzheimer Disease Treatment

  The NeuroResearch Clinics Alzheimer Disease Treatment involves neurotransmitter optimization of the master neurotransmitters of the brain serotonin, dopamine, norepinephrine and epinephrine. These neurotransmitters directly and indirectly control virtually every function in the brain and body. NeuroResearch Clinics uses 5-HTP, tyrosine, levodopa, and cysteine guided by neurotransmitter testing as indicted to restore brain function and get other symptoms under control in Alzheimer Disease. For the Alzheimer patients most show significant improvement of cognitive brain function. 15% to 20% of Alzheimer Disease Treatment achieve profound restoration of  brain function. Please, read the case studies in the right brown colored column, these were written by medical doctors (MDs) based on medical care experiences. Restoration of the brain in Alzheimer Disease is aimed at neurotransmitter optimization is in a league of its own, beyond results seen with any prescription drug in the past.

  Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa, and cysteine in Alzheimer Disease Treatment to get these results. Proper use of these simple ingredients in medical treatment is not simple. From time to time a patient will say, "Why do I want to take that, I can go to a health food store and buy it?" People off the street buying in a health food store is like going to an art store and buying a bunch of oil paints then going home and expecting to paint like a mater artist even though there was no previous painting experience. These nutrients have tremendous potential due to their chemical properties. This potential is only fully realized in the hands of the trained professional using neurotransmitter testing. Treatment is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control.

Alzheimer Disease Treatment
- Alzheimer Disease Treatment home page

- Case study #1

- Case study #2

- Case study #3

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Alzheimer Disease Treatment

SYMPTOMS

  While deterioration of brain function takes the spot light in the Alzheimer Disease Treatment there are many other problems that can be active, including:

  • Sleep patterns, Many Patient suffer from abnormal sleep patterns, up during the night wandering around or sleeping during the day. With serotonin and dopamine optimization normal sleep patterns are restored in the Patient.

  • Inappropriate anger, aggression, or yelling out, is a problem with some Patient. With serotonin and dopamine optimization inappropriate anger, aggression, or yelling out are controlled in the patient.

  • Agitation, many Patient suffer from inappropriate agitation. This may take the form of mental or physical agitation. With serotonin and dopamine optimization agitation is controlled in the patient.

  • Depression is common in Patient. Depression may display as an agitated depression. In medicine there is no drug that effectively controls depression in the elderly, with or without Alzheimer. With neurotransmitter optimization of serotonin and dopamine guided by neurotransmitter testing when indicated depression is controlled.

  • Anxiety, may be present. With neurotransmitter optimization of serotonin and dopamine guided by neurotransmitter testing as indicted, anxiety in the patients may be controlled.

  • Psychotic state is a significant problem with Patient talking about and hearing or seeing things that are not there. With neurotransmitter optimization of serotonin and dopamine guided by neurotransmitter testing as indicated, the patients may experience control of inappropriate perceptions.

  • Restless Leg Syndrome is common, contributing greatly sleep disturbance which leads to exacerbation of cognitive problems. With neurotransmitter optimization of serotonin and dopamine guided by neurotransmitter testing as indicted, Restless Leg Syndrome in the patients can be controlled.

The Peer Reviewed Research of NeuroResearch Clinics

  The neurotransmitter treatment research findings of NeuroResearch Clinics have not been ignored. The University of Minnesota Medical School is writing a series of papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "The Journal of NeuroPsychiatry" May 1, 2009. Ingrid Kohlstadt, MD of Johns Hopkins in her new medical text book released February 7, 2009 included a chapter on depression written by Marty L. Hinz, MD  President Clinical Research NeuroResearch Clinics outlining in depth the proper use of amino acids and neurotransmitter testing in treatment of depression.

University of Minnesota Medical School neurotransmitter testing paper on the research of NeuroResearch Clinics.

 

The medical text book chapter on depression written by Marty L. Hinz, MD-Ingrid Kohlstadt, MD editor-Johns Hopkins released February, 7, 2009

Alzheimer Disease Treatment

 

WHAT CAUSES

Alzheimer?

Elevation of neurotransmitter levels, guided by neurotransmitter testing, reveals excellent results in  Alzheimer treatment. Review of neurotransmitter testing prior to Care reveals that Patient with Alzheimer, as a group, have virtually the same neurotransmitter levels as those that do not. Therefore low levels of neurotransmitters are not the cause of Alzheimer.

The primary cause of Alzheimer  appears to be brain damage. The leading cause is neurotoxic damage. Just as with Parkinson's Care Patient elevating neurotransmitter levels restores flow of electricity in the brain compensating for brain damage, restoring normal function, and relieving symptoms.

 

Alzheimer Disease Treatment Links

Alzheimer Disease Treatment organization

Alzheimer Disease Treatment Medline

Alzheimer Disease Treatment Mayo

Alzheimer Disease Treatment Foundation

Alzheimer Disease Treatment news

 

 
If you need a medical speaker for AMA Category I CME call NeuroResearch Clinics, Inc.
NeuroResearch Clinics, Inc. only deals with and provides information to licensed health care professionals.
 
Alzheimer Disease Treatment
 
keyz keyb
 
Alzheimer Disease Treatment